Morningstar® Stock Report™

Core Laboratories Inc CLB

Gewinnmarge (% des Umsatzes)
20182019202020212022
Ertrag100,00%100,00%100,00%100,00%100,00%
Betriebskosten74,20%77,55%81,19%82,17%83,89%
Bruttogewinn25,80%22,45%18,81%17,83%16,11%
Vertriebsgemeinkosten8,98%7,19%6,98%9,39%7,78%
Forschung und Entwicklung-----
Umsatzrendite16,82%15,27%11,82%8,44%8,33%
Net Int, Inc and Other31,84%27,54%-6,89%16,11%14,45%
EBIT Marge15,02%12,27%-18,71%7,68%6,12%
Ertragskraft
20182019202020212022
Steuersatz3,63%-1,84%1,21%3,38%2,10%
Nettomarge11,35%15,26%-20,04%4,19%3,97%
Gesamtkapitalrendite12,8914,33-14,543,433,36
Financial Leverage4,144,367,953,713,14
Eigenkapitalsrendite52,7460,95-78,3017,3111,42